[Therapeutic effectiveness of the Russian drug reaferon in hairy cell leukemia]

The results of the clinical trial of Soviet reaferon in 16 patients with hairy-cell leukemia have been presented. Clinicohematological effect of the drug has been ascertained in 62% of the cases. It has been established that the agent is well-tolerated and produces a good antitumor effect. Doses and regimens of the drug administration to hairy-cell leukemia patients have been developed.